Yash Pharmaceuticals – FDA 483, Sep 3, 2019
Yash Pharmaceuticals, an OTC drug products manufacturer in Roorkee, India, was cited for significant deficiencies across its quality control, manufacturing, and laboratory operations. Observations included inadequate laboratory controls for product specifications and testing, lack of appropriate stability data for expiration dates, and failure to use tamper-evident packaging. Additionally, the firm had unvalidated and insufficient cleaning procedures, unqualified filling equipment, poor equipment maintenance, unsecured label storage, and a deficient quality control unit that failed to follow or adequately establish critical procedures.
ID · ed7b0af2-c8e1-49b8-b8bb-6aa85826bfea
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.